Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

The name of the unit – whose brands include Sensodyne toothpaste and Voltaren and Panadol ... that will provide details of GSK's plans for the business, which has annual sales of around £ ...

Sensodyne's brand purpose is to create an oral care future that is sensitivity‐free; we wanted to create a mobile-first digital experience that would help the brand achieve this goal. While the legacy ...

GSK's consumer health spinout Haleon started ... a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and Centrum ...

A major employer in Dungarvan has seen Pfizer, its single largest shareholder, sell its entire stake in the company for ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...

In preparation of separating from GSK, its former parent ... Consult studied consumer loyalty associated with brands and found that toothpaste ranked second out of a group of personal-care ...

Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.

Compete against established giants and scrappy upstarts to launch a new, novel toothpaste. We’re long-term subscribers ... In compiling a recent case for long-term, sustained investment in brand, we ...